Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Raplixa
ID: S900006970


  • FDA: Raplixa is a biological product approved for use in adults to help control bleeding from small blood vessels when standard surgical techniques, such as suture, ligature or cautery, are ineffective or impractical. When applied to a bleeding site, Raplixa is dissolved in the blood and a reaction starts between the fibrinogen and thrombin proteins. This results in the formation of blood clots to help stop the bleeding. (FDA Press Release April 30, 2015)
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Raplixa


  • Fibrocaps
  • Raplixa

Registry Number

  • S900006970